Emerald Heath Pharmaceuticals is a biotech company developing novel therapies for neurodegenerative and autoimmune diseases. Including multiple sclerosis, systemic sclerosis (a form of scleroderma), Parkinson's disease and Huntington's disease. References/Sources: - National Multiple Sclerosis Society - Parkinson’s Foundation - Huntington’s Disease Society of America - Scleroderma Foundation - Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025 Research and Markets Report - Scleroderma Diagnostics and Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024 Transparency Market Research Report - Parkinson's Disease Therapeutics Market Global Industry Analysis Size, Share, Growth ,Trends, and Forecasts, 2017 To 2025 Transparency Market Research Report - Opportunity Analyzer: Huntington's Disease Opportunity Analysis and Forecast to 2024 Research and Markets Report